Impact Factor 4.019

The world's most-cited Microbiology journal

Original Research ARTICLE

Front. Microbiol., 16 July 2015 | https://doi.org/10.3389/fmicb.2015.00723

In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells

Emanuela Roscetto1*, Laura Vitiello2, Rosa Muoio1, Amata A. Soriano1, Vita D. Iula1, Antonio Vollaro3, Eliana De Gregorio1* and Maria R. Catania1
  • 1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Federico II, Napoli, Italy
  • 2Laboratorio di Immunologia Cellulare e Molecolare, Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Pisana, Rome, Italy
  • 3DAI Medicina di Laboratorio, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy

Stenotrophomonas maltophilia is increasingly identified as an opportunistic pathogen in immunocompromised, cancer and cystic fibrosis (CF) patients. Knowledge on innate immune responses to S. maltophilia and its potential modulation is poor. The present work investigated the ability of 12 clinical S. maltophilia strains (five from CF patients, seven from non-CF patients) and one environmental strain to survive inside human monocyte-derived dendritic cells (DCs). The effects of the bacteria on maturation of and cytokine secretion by DCs were also measured. S. maltophilia strains presented a high degree of heterogeneity in internalization and intracellular replication efficiencies as well as in the ability of S. maltophilia to interfere with normal DCs maturation. By contrast, all S. maltophilia strains were able to activate DCs, as measured by increase in the expression of surface maturation markers and proinflammatory cytokines secretion.

Introduction

The environmental Gram-negative bacillus Stenotrophomonas maltophilia is increasingly identified as an opportunistic nosocomial pathogen for susceptible individuals, including immunocompromised, cancer, and cystic fibrosis (CF) patients (Brooke, 2012; Waters et al., 2013). Cases of community-acquired S. maltophilia infections have also been reported (Falagas et al., 2009b; Chang et al., 2014). Molecular analyses have revealed considerable heterogeneity among S. maltophilia isolates, including those coming from just one hospital (Roscetto et al., 2008; Kaiser et al., 2009; Rocco et al., 2009).

The intrinsic resistance to a wide spectrum of antibiotics (Crossman et al., 2008; Brooke, 2014), the ability to adhere and form biofilm on medical devices surfaces and airway epithelial cells (Pompilio et al., 2010), make S. maltophilia responsable of persistent nosocomial infections. S. maltophilia can cause various serious infections but it is most commonly associated with pneumonia (Weber et al., 2007; Chang et al., 2014; Chawla et al., 2014). S. maltophilia pneumonia may be complicated by persistent bacteremia associated with a significant increased mortality (Elsner et al., 1997; Falagas et al., 2009a).

Little is known about pathogenesis of S. maltophilia, and the genomic diversity exhibited by clinical isolates makes difficult the identification of pathogenic traits. Factors likely involved in the pathogenesis of S. maltophilia have been described (Chhibber et al., 2008; Pompilio et al., 2011; Roscetto et al., 2012). The ability to adhere and penetrate inside airway epithelial cell lines (Pompilio et al., 2010), and stimulate robust cytokine production in macrophages and monocytes are key steps in S. maltophilia infections (Waters et al., 2007; Härtel et al., 2013). Little is known on the interactions between S. maltophilia and dendritic cells (DCs). Immature DCs (iDCs) are sentinel cells found in skin, respiratory and gastrointestinal mucosae constantly recruited from blood to peripheral tissues, even in the absence of inflammatory processes (Guermonprez et al., 2002). Upon capture of soluble antigens or bacteria, iDCs undergo maturation, a profound change in gene expression transforming them from antigen-capturing to mature antigen-processing and -presenting cells (Guermonprez et al., 2002; Villadangos and Health, 2005).

Mature DCs migrate to secondary lymphoid organs to prime naïve T cells differentiation into effector T cells (Reis e Sousa, 2006). DCs produce interleukin-12p70 (IL-12p70), which activates the differentiation of T helper 1 (Hsieh et al., 1993) and cytotoxic T cells, and IL-1 beta, IL-6, and IL-23, required for differentiation of Th17 cells (Acosta-Rodriguez et al., 2007). Pathogenic bacteria have developed strategies which enable them to escape phagocytosis and killing by DCs, or affect DC maturation (Bueno et al., 2012).

The aim of this study was to compare the ability of S. maltophilia strains from CF and non-CF patients to survive in human monocyte-derived DCs, and evaluate whether isolates from CF patients have unique properties. We also examined the effect of S. maltophilia strains on the maturation of DCs, monitoring the expression of specific maturation markers by flow cytometry.

Materials and Methods

Bacterial Strains and Culture Conditions

Thirteen non-clonal clinical isolates of S. maltophilia were included in the study. Strains were isolated from diverse clinical settings, including CF and non-CF respiratory specimens, as well as non-respiratory specimens, collected at the Laboratory of Clinical Microbiology, University Federico II of Naples. The sequenced strain K279a was kindly provided by M. B. Avison (University of Bristol, Bristol, UK). The environmental strain LMG11104 was obtained from the BCCM (Belgium Coordinated Collections of Microorganisms/Laboratorium) voor Microbiologie Ghent, University of Ghent, Belgium. Details of the bacterial strains used in this study are given in Table 1. Bacteria were identified as S. maltophilia by biochemical characteristics and antibiotic resistance analysis, using the VITEK II system (bioMerieux) and confirmed by MALDI TOF MS (Bruker). Bacteria were grown overnight at 37°C for 24 h in Brain-Hearth Infusion broth (BHI; Becton Dickinson), and aliquots were frozen in BHI-glycerol at –80°C until use.

TABLE 1
www.frontiersin.org

Table 1. Stenotrophomonas maltophilia strains used in DC infection assay.

Motility Assays

Swimming motility was evaluated on plates 1% tryptone, 0.5% NaCl containing 0.3% agar. A colony of bacteria was inoculated with a sterile toothpick placed directly into the center of the agar. After incubation for 48 h at 30°C, the diameters of the swimming motility zones were measured. Twitching motility was evaluated on plates 1% tryptone, 0.5% yeast extract, 0.5% NaCl containing 1% agar. A colony of bacteria was inoculated deep into the agar with a sterile toothpick at the bottom of twitch plates. After incubation at 37°C for 24 h, the zone of motility at the agar-petri dish interface was measured by staining with 1% crystal violet.

Biofilm Assay

Biofilm formation was tested in 96-well microtiter plates according to Stepanovic et al. (2000). Briefly, one colony of the overnight cultures of bacterial strains was diluted in trypticase soy broth (TSB) in order to adjust the turbidity of the bacterial suspension to 0.5 McFarland standard, approximately 108 CFU (colony forming units)/mL. Bacterial suspension was diluted 1:100 in TSB and 200 μL of the diluted bacteria was added to each well. Negative control wells contained broth only. The plates were incubated aerobically for 48 h at 37°C. Thereafter, the content of each well was aspirated and the wells washed three times with 300 μl of sterile phosphate buffered saline (PBS). Biofilm was fixed incubating microtiter plates for 1 h at 60°C. The plates were stained with 30 μl per well of 1% crystal violet for 15 min and washed with 150 μl of sterile PBS. The dye bound to the adherent cells was resolubilized with 150 μl of 95% ethanol per well. The optical density of each well was measured at 630 nm using a microplate reader (Biorad). Based on the optical densities of bacterial biofilms, all strains were classified into the following categories: no biofilm producers (–), weak (+), moderate (+), or strong (+++) biofilm producers, as previously described (Stepanovic et al., 2000).

In vitro Generation and Culture of Human DCs

Immature dendritic cells were generated from peripheral blood mononuclear cells, as described (Sallusto and Lanzavecchia, 1994). Briefly, peripheral blood mononuclear cells were obtained from 30 ml of leukocyte-enriched buffy coat from healthy donors by centrifugation on a Ficoll-Hypaque plus (GE Healthcare) through density gradient. Monocytes were purified by positive selection using anti-CD14 mAb-conjugated magnetic microbeads (Miltenyi Biotec). CD14+ cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum (Invitrogen), and 2 mM glutamine (Invitrogen) containing 50 ng/ml GM-CSF (granulocytes monocytes-colony stimulating factor) and 250 ng/ml IL-4 (Immunotools). Cells were cultured for 5–7 days in 5% CO2 atmosphere to obtain a population of iDCs. Purity of generated DCs was checked by flow cytometry, using Phycoerythrin (PE) conjugated anti-CD1a antibody (Becton Dickinson) on a FACScalibur flow cytometer (Becton Dickinson). DC populations were used when CD1a expression was > 95%. Written informed consent was obtained from each donor at the time of venous peripheral blood donation, in accordance with the Declaration of Helsinki, as approved by Azienda Ospedaliera Universitaria Federico II. All the experiments done by using blood donations were performed and analyzed anonymously, without any biographical reference to donors.

DC Infection Assays

iDCs were seeded at a concentration of 106 cells per well into 24-wells culture plates, infected with 2 × 107 CFU/ml of mid-log growth phase S. maltophilia cells to yield bacterium-to-dendritic cell ratio of 20:1 and incubated for 1 h at 37°C in 5% CO2.

To assess the number of intracellular bacteria, the culture medium was gently removed, cells were washed twice with sterile PBS and further incubated for 1 h in fresh medium containing 600 μg/ml gentamicin or 1 mg/ml ceftazidime to kill extracellular bacteria. DCs were subsequently washed and incubated in 10 mM EDTA, 0.25% Triton X-100 (Sigma) for 5 min to release internalized bacteria. Lysates were serially diluted 1:10 and plated on TSA (Becton Dickinson) to quantify the number of viable intracellular bacteria. Entry Index (EI), i.e., the percentage (mean) of the inoculated CFUs that were internalized by iDCs after 1 h of infection, was determined as follows: EI = (CFU ml–1 recovered from DCs after 1 h of infection/CFU ml–1 applied to DCs) × 100.

To measure intracellular replication, after infection of DCs with S. maltophilia and antibiotic treatment cells were extensively washed and fresh medium was added. Incubation was continued for additional 16 h. After washing three times with PBS, intracellular bacteria were released by addition of 10 mM EDTA, 0.25% Triton X-100 and the number of CFU was determined by plating 10-fold dilutions on TSA. Intracellular Replication Index (RI), i.e., the percentage (mean) of the internalized CFUs that survived by iDCs after 18 h of infection, was determined as follows: RI = (CFU ml–1 recovered from DCs after 18 h of infection/CFU ml–1 recovered from DCs after 1 h of infection) × 100.

The bactericidal activity of gentamicin or ceftazidime at the used concentrations had been previously assessed. The effectiveness of drugs during infection assays was tested by supernatant sampling before DCs lysis and plating on TSA (data not shown).

DCs Maturation Analysis

Dendritic cells were seeded in 24-well plates at a concentration of 106 cells/ml and then exposed to RPMI 1640 only, 1 mg/ml LPS or live bacteria at an MOI of 20:1. After 18 h of incubation at 37°C and 5% CO2, DCs were harvested, washed, re-suspended in FACS buffer and DC maturation was then analyzed measuring CD86 and CD80 expression by flow cytometry, using FITC-conjugated anti-CD80 antibody and a PE-conjugated anti-CD86 antibody (Becton Dickinson).

For TNFα expression, cells were cultured for 2 h with the bacterial strains in the presence of 5 mg/ml Brefeldin A (Sigma) and then stained with anti-TNFα antibody (Becton Dickinson) using Cytofix/Cytoperm method (Becton Dickinson), according to manufacturer’s instructions. IL -12p70 production by DCs was measured from supernatants using OptEIA ELISA kits (Becton Dickinson), according to manufacturer’s instructions.

Statistical Analysis

All assays were performed in three independent experiments. Paired Student’s t-test was used to evaluate the statistical differences between uninfected-DCs and S. maltophilia-infected DCs and between CFUs recovered from DCs after 1 h and after 17 h of incubation for each analyzed strain. Statistical differences between multiple groups of S. maltophilia strains were assessed using a Mann-Whitney non-parametric test. Values of p < 0.05 were taken as statistically significant differences.

Results

Internalization and Intracellular Replication of S. maltophilia in Immature Monocytes-derived Dendritic Cells

We have selected 13 strains from diverse clinical setting (Table 1). Some were isolated from the respiratory tract of CF patients (group 1, CF strains), others from the respiratory tract of non-CF patients (group 2, NCF strains), the remaining from non-respiratory specimens (group 3, NR strains). Motility is crucial both to colonize an environment and to induce formation of structured surface-associated communities of bacteria called biofilm. For each strain, both motility and the ability to form biofilm in polystyrene microtiter plates were analyzed. All CF and NR strains exhibited reduced swimming and twiching motilities compared to NCF strains (Table 1). Biofilm forming ability greatly varied among strains tested (OD630 range: 0.08–1.2). Most CF strains (80%) were moderate biofilm producers, whereas the majority of the NCF and NR strains (75%) were strong producers (Table 1). Strong biofilm producers exhibited increased swimming and twitching activity.

The uptake and intracellular replication were analyzed by infecting immature monocytes-derived DCs (iDCs) with tested S. maltophilia strains at a MOI of 20. All strains were internalized and were able to survive within iDCs, but internalization and replication significantly varied among strains of the same group, as among strains of different groups (Figure 1). The difference between CFUs at 1 h and 18 h of infection resulted statistically significant (p < 0.05) for 11/13 strains (Figure 1). Values of Entry Index (EI) of CF strains ranged from 1.35 for (CF1445 strain) to 4.6 (CF1545 strain; Figure 2A). Only the CF781 strain was able to grow intracellularly (p < 0.05) with Intracellular Replication Index (RI) of 166.7 (Figure 2B). EI values of NCF strains ranged from 1,6 (NCF 1489 strain) to 14.38 (NCF2035 strain; Figure 2A). Two NCF isolates (NCF879 and NCF2035 strains) were able to multiply intracellularly (p < 0.05) with RI mean values of 140.38 and 170.83 respectively (Figure 2B). Among NR strains, only the K279a strain could survive into iDCs, but was unable to replicate, because no significant differences (p = 0,27) between CFUs at 1 h and 18 h were found (Figure 1). In spite of the limited number of clones analyzed, no significative difference could be observed among CF, NCF, and NR strains. This weakens the hypothesis made by several groups suggesting that unique properties may be associated to CF strains (see Waters et al., 2007).

FIGURE 1
www.frontiersin.org

Figure 1. Interactions of S. maltophilia strains with iDCs. White and gray bar graphs indicate CFUs recovered by iDCs after 1 h and 18 h of infection, respectively. *p < 0.05. Each bar indicates the mean value ± standard deviation of at least three independent experiments in triplicate.

FIGURE 2
www.frontiersin.org

Figure 2. DC infection assays. (A) Entry Index (EI). Bar graphs shown the percentage internalization of S. maltophilia strains after 1 h of infection with DCs. (B) Intracellular Replication Index (RI). Bar graphs shown the percentage survival of S. maltophilia strains after 18 h of infection within DCs. Each bar indicates the mean value ± standard deviation of at least three independent experiments in triplicate.

S. maltophilia Induces DCs Maturation

Changes induced in DCs by tested strains were assessed by measuring by flow cytometry the expression of CD86 and CD80, two costimulatory molecules upregulated during DC maturation. As revealed by the fold increase in mean fluorescence intensity (MFI) of CD80 and CD86 (Figure 3), most strains induced a consistent upregulation of both molecules. Only for the NCF2035 strain no statistically significative difference in the expression of both CD80 and CD86 in infected and uninfected cells could be observed.

FIGURE 3
www.frontiersin.org

Figure 3. Stenotrophomonas maltophilia strains induce dendritic cells maturation. Bar graphs shown the fold change in CD80 (A) and CD86 (B) expression after 18 h of incubation. CD86 and CD80 expression on DCs was measured by flow cytometry. The mean fluorescence intensity (MFI) reflects the upregulation of molecule on cell surface. Each bar indicates the mean ± standard deviation of three independent experiments. *p < 0.05. Medium: iDCs uninfected.

Along with changes in the expression of surface maturation markers, DC secrete several cytokines in response to intracellular infection. All strains induce a statistically significative (p < 0.001) increase of TNFα and IL-12 cytokines (Figure 4). Also in DCs maturation, no significant differences (p > 0.05) was observed by comparing CF isolates to either NCF or NR strains.

FIGURE 4
www.frontiersin.org

Figure 4. Stenotrophomonas maltophilia strains induce cytokines production by dendritic cells. Bar graphs shown the production of IL-12 (A) and TNFα (B) by dendritic cells after incubation with the S. maltophilia strains. IL-12 and TNFα expression by DCs was measured by ELISA and flow cytometry, respectively. Each bar indicates mean ± standard deviation of at three independent experiments. All the bacterial strains induced the production of TNFα and IL-12 by DCs (p < 0.001). Medium: iDCs uninfected.

Discussion

By sensing danger signals in peripheral tissues, iDCs activate both adaptive and innate immunity, leading to bacterial clearance. Several microbial pathogens are able to avoid or subvert DCs, thwarting DC differentiation, survival, maturation, antigen processing and presentation and the induction of T cell immunity (Rescigno, 2015). This is the first report of the interaction between human monocyte-derived DCs and S. maltophilia. All the analyzed strains were internalized by DCs (Figure 1), but the efficiency of internalization and intracellular survival differed highly (Figure 2). Six of thirteen strains exhibited low EI values, and were unable to persist inside host cells. Thus, these S. maltophilia isolates plausibly escape the effector cells of innate immunity by circumventing phagocytosis. Four strains showed high EI values, and two (NFC879 and NFC2035) also exhibited high RI values. NFC879- and NFC2035-like strains could safely be mobilized in the host evading antimicrobial therapy and immune response. The intracellular survival and replication could contribute to S. maltophilia virulence, and DCs may serve as dissemination vectors of bacteria outside of the infection site. Monitoring changes in gene expression occurred in bacteria recovered by DCs after 1 h and 18 h of infection could eventually help to clarify the intracellular survival strategy of S. maltophilia inside DCs.

Most of tested strains induced a significant increase in the expression of DC surface maturation markers (Figure 3). This suggests that DCs exposed to S. maltophilia can prime naïve T cells. Noteworthy, the NFC2035 strain, which exhibited the highest RI value, selectively failed to upregulate CD80 and CD86 costimulatory molecules. Pathogens as diverse as Mycobacterium tuberculosis, HIV-1, and Leishmania sp., downregulate the expression of costimulatory molecules in order to establish chronic infection. Impairment in the signaling events delivered by costimulatory molecules may be responsible for defective T-cell responses, enabling infective organisms to grow unhindered in the host cells (Khan et al., 2012).

All tested strains were able to induce the production of TNFα and IL-12 in DCs (Figure 4), and this is on line with data obtained by monitoring the response of macrophages to S. maltophilia (Waters et al., 2007). The production of both cytokines may play a crucial role in tissue inflammation, and contribute to a slow damage in CF lung. Clinical retrospective studies indeed showed deterioration of lung function after prolonged colonization with S. maltophilia in CF- as in hospital-acquired pneumonias (Karpati et al., 1994).

No significant difference was observed in the maturation of iDCs stimulated with S. maltophilia strains belonging to CF, NCF, and NR group. The data suggested that internalization, intracellular survival and immunostimulatory properties of S. maltophilia are strain-dependent. This is in accord with studies showing that different S. maltophilia strains replicate and persist in the murine lungs to significantly different degrees (Rouf et al., 2011). The observed heterogeneity is not surprising, in light of the high genetic diversity exhibited by S. maltophilia isolates (Roscetto et al., 2008; Kaiser et al., 2009; Rocco et al., 2009).

Further experiments will be needed to characterize the DC-driven T-cell responses, analyzing the ability of DCs infected with S. maltophilia to bias naive allogenic T-cell differentiation toward a TH1 or TH2 phenotype.

Author Contributions

All authors read and approved this manuscript. ER and MC conceived and designed the experiments. ER, LV, RM, and AS performed the experiments. ER, LV, and EDG analyzed the data. VI and AV provided strains for analysis. The manuscript was prepared by ER, EDG, and MC.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by PON Ricerca e competitività 2007–2013 of the Agency of the Italian Ministry of University and Scientific Research (PON01_02589). We are indebted to Pierpaolo Di Nocera for comments and critical reading of the manuscript.

References

Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., and Sallusto, F. (2007). Interleukins 1β and 6 but not transforming growth factor- β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942–949. doi: 10.1038/ni1496

PubMed Abstract | CrossRef Full Text | Google Scholar

Brooke, J. S. (2012). Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25, 2–41. doi: 10.1128/CMR.00019-11

PubMed Abstract | CrossRef Full Text | Google Scholar

Brooke, J. S. (2014). New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen. Expert Rev. Anti Infect. Ther. 12, 1–4. doi: 10.1586/14787210.2014.864553

PubMed Abstract | CrossRef Full Text | Google Scholar

Bueno, S. M., Riquelme, S., Riedel, C. A., and Kalergis, A. M. (2012). Mechanisms used by virulent Salmonella to impair dendritic cell function and evade adaptive immunity. Immunology 137, 28–36. doi: 10.1111/j.1365-2567.2012.03614.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Chang, Y. T., Lin, C. Y., Lu, P. L., Lai, C. C., Chen, T. C., Chen, C. Y., et al. (2014). Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections. J. Microbiol. Immunol. Infect. 47, 28–35. doi: 10.1016/j.jmii.2012.08.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Chawla, K., Vishwanath, S., and Gupta, A. (2014). Stenotrophomonas maltophilia in Lower Respiratory Tract Infections. J. Clin. Diagn. Res. 8, DC20–DC22. doi: 10.7860/jcdr/2014/10780.5320

PubMed Abstract | CrossRef Full Text | Google Scholar

Chhibber, S., Gupta, A., Sharan, R., Gautam, V., and Ray, P. (2008). Putative virulence characteristics of Stenotrophomonas maltophilia: a study on clinical isolates. World J. Microbiol. Biotechnol. 24, 819–825. doi: 10.1007/s11274-008-9812-5

CrossRef Full Text | Google Scholar

Crossman, L. C., Gould, V. C., Dow, J. M., Vernikos, G. S., Okazaki, A., Sebaihia, M., et al. (2008). The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9:R74. doi: 10.1186/gb-2008-9-4-r74

PubMed Abstract | CrossRef Full Text | Google Scholar

Elsner, H. A., Duhrsen, U., Hollwitz, B., Kaulfers, P. M., and Hossfeld, D. K. (1997). Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by S. maltophilia. Ann. Hematol. 74, 155–161. doi: 10.1007/s002770050275

PubMed Abstract | CrossRef Full Text | Google Scholar

Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., Rafailidis, P. I., Kapaskelis, A. M., and Dimopoulos, G. (2009a). Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 4, 1103–1109. doi: 10.2217/fmb.09.84

PubMed Abstract | CrossRef Full Text | Google Scholar

Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., and Dimopoulos, G. (2009b). Community-acquired Stenotrophomonas maltophilia infection: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis. 28, 719–730. doi: 10.1007/s10096-009-0709-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cell. Annu. Rev. Immunol. 20, 621–667. doi: 10.1146/annurev.immunol.20.100301.064828

PubMed Abstract | CrossRef Full Text | Google Scholar

Härtel, C., Scholz, T., Kuhn, M., Bendiks, M., Göpel, W., Lauten, M., et al. (2013). Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine. J. Microbiol. Immunol. Infect. 46, 115–120. doi: 10.1016/j.jmii.2012.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O’Garra, A., and Murphy, K. M. (1993). Development of TH1 CD4T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547–549. doi: 10.1126/science.8097338

PubMed Abstract | CrossRef Full Text | Google Scholar

Kaiser, S., Biehler, K., and Jonas, D. (2009). A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure. J. Bacteriol. 191, 2934–2943. doi: 10.1128/JB.00892-08

PubMed Abstract | CrossRef Full Text | Google Scholar

Karpati, F., Malmborg, A. S., Alfredsson, H., Hjelte, L., and Strandvik, B. (1994). Bacterial colonisation with Xanthomonas maltophilia—a retrospective study in a cystic fibrosis patient population. Infection 22, 258–263. doi: 10.1007/BF01739911

PubMed Abstract | CrossRef Full Text | Google Scholar

Khan, N., Gowthaman, U., Pahari, S., and Agrewala, J. N. (2012). Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!. PLoS Pathog. 8:e1002676. doi: 10.1371/journal.ppat.1002676

PubMed Abstract | CrossRef Full Text | Google Scholar

Pompilio, A., Crocetta, V., Confalone, P., Nicoletti, M., and Petrucca A, Guarnieri S. et al. (2010). Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. 10:102. doi: 10.1186/1471-2180-10-102

PubMed Abstract | CrossRef Full Text | Google Scholar

Pompilio, A., Pomponio, S., Crocetta, V., Gherardi, G., Verginelli, F., Fiscarelli, E., et al. (2011). Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. BMC Microbiol. 11:159. doi: 10.1186/1471-2180-11-159

PubMed Abstract | CrossRef Full Text | Google Scholar

Reis e Sousa, C. (2006). Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476–483. doi: 10.1038/nri1845

PubMed Abstract | CrossRef Full Text | Google Scholar

Rescigno, M. (2015). Dendritic cell functions: learning from microbial evasion strategies. Semin. Immunol. 27, 119–124. doi: 10.1016/j.smim.2015.03.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Rocco, F., De Gregorio, E., Colonna, B., and Di Nocera, P. P. (2009). Stenotrophomonas maltophilia genomes: a start-up comparison. Int. J. Med. Microbiol. 299, 535–546. doi: 10.1016/j.ijmm.2009.05.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Roscetto, E., Angrisano, T., Costa, V., Casalino, M., Förstner, K. U., Sharma, C. M., et al. (2012). Functional characterization of the RNA chaperone Hfq in the opportunistic human pathogen Stenotrophomonas maltophilia. J. Bacteriol. 194, 5864–5874. doi: 10.1128/JB.00746-12

PubMed Abstract | CrossRef Full Text | Google Scholar

Roscetto, E., Rocco, F., Carlomagno, M. S., Casalino, M., Colonna, B., Zarrilli, R., et al. (2008). PCR-based rapid genotyping of Stenotrophomonas maltophilia isolates. BMC Microbiol. 8:202. doi: 10.1186/1471-2180-8-202

PubMed Abstract | CrossRef Full Text | Google Scholar

Rouf, R., Karaba, S. M., Dao, J., and Cianciotto, N. P. (2011). Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees. Microbiology 157, 2133–2142. doi: 10.1099/mic.0.048157-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109–1118. doi: 10.1084/jem.179.4.1109

PubMed Abstract | CrossRef Full Text | Google Scholar

Stepanovic, S., Vukovic, D., Dakic, I., Savic, B., and Svabic-Vlahovic, M. (2000). A modified microtiter plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 40, 175–179. doi: 10.1016/S0167-7012(00)00122-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Villadangos, J. A., and Health, W. R. (2005). Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells. Limitations of the Langerhans cell paradigm. Sem. Immunol. 17, 262–272. doi: 10.1016/j.smim.2005.05.015

PubMed Abstract | CrossRef Full Text | Google Scholar

Waters, V., Atenafu, E. G., Lu, A., Yau, Y., Tullis, E., and Ratjen, F. (2013). Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J. Cyst. Fibros. 12, 482–486. doi: 10.1016/j.jcf.2012.12.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Waters, V. J., G-ez, M. I., Soong, G., Amin, S., Ernst, R. K., and Prince, A. (2007). Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect. Immun. 75, 1698–1703. doi: 10.1128/IAI.01469-06

PubMed Abstract | CrossRef Full Text | Google Scholar

Weber, D. J., Rutala, W. A., Sikbert-Bennet, E. E., Samsa, G. P., Brown, V., and Niederman, M. S. (2007). Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect. Control Hosp. Epidemiol. 28, 825–831. doi: 10.1086/518460

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: DC maturation markers, cytokines secretion, cystic fibrosis, opportunistic pathogen, innate immune response

Citation: Roscetto E, Vitiello L, Muoio R, Soriano AA, Iula VD, Vollaro A, De Gregorio E and Catania MR (2015) In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells. Front. Microbiol. 6:723. doi: 10.3389/fmicb.2015.00723

Received: 11 May 2015; Accepted: 02 July 2015;
Published: 16 July 2015.

Edited by:

Giovanni Di Bonaventura, “G. d’Annunzio” University of Chieti-Pescara, Italy

Reviewed by:

Mattias Collin, Lund University, Sweden
Malgorzata A. Mikaszewska-Sokolewicz, The Medical University of Warsaw, Poland

Copyright © 2015 Roscetto, Vitiello, Muoio, Soriano, Iula, Vollaro, De Gregorio and Catania. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Emanuela Roscetto and Eliana De Gregorio, Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Federico II, Via Sergio Pansini 5, Napoli 80131, Italy, emanuelaroscetto@gmail.com; edegrego@unina.it